During a Case-Based Roundtable® event, Neeraj Agarwal, MD, and participants discussed how they might determine which ...

A study showed notable differences in bone mineral density between children on steroids and those not on steroids, with 84% ...

Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function ...

Their findings, published in Nature Neuroscience, show that renal dysfunction can cause the accumulation of α-synuclein in ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Keeping blood pressure under control is critical. For patients who have been unable to successfully maintain that control, there is a new, cutting-edge surgical procedure available at The Heart Center ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

WALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development of its ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

VitusCare has developed proprietary playbooks to find the right hospital partners, fast-track centre-launches and use ...